Detalles de la búsqueda
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
2.
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
Oncology
; 99(5): 292-299, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626532
3.
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer.
Liver Int
; 40(3): 704-711, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31773848
4.
Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer.
HPB (Oxford)
; 22(1): 116-123, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235431
5.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474758
6.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
7.
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
Support Care Cancer
; 27(12): 4697-4704, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949832
8.
Reversibility of chemotherapy-related liver injury.
J Hepatol
; 67(1): 84-91, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28284915
9.
Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
Ann Surg
; 260(5): 878-84; discussion 884-5, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25379857
10.
Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer: a single institutional experience.
Cancer
; 119(2): 277-84, 2013 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22778019
11.
Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.
Ann Surg Oncol
; 20(3): 938-45, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23010733
12.
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study.
Oncologist
; 17(11): 1430-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956535
13.
Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades.
Ann Surg Oncol
; 19(6): 2035-44, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22219066
14.
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
J Chemother
; 34(8): 543-549, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156913
15.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index.
J Gastrointest Cancer
; 53(3): 528-536, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34033000
16.
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
Explor Target Antitumor Ther
; 2(5): 448-464, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045702
17.
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis.
Eur J Cancer
; 146: 145-154, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33607478
18.
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
Recenti Prog Med
; 111(12): 740-748, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33362171
19.
Second-line treatment options in hepatocellular carcinoma.
Drugs Context
; 8: 212577, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31024634
20.
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
Clin Colorectal Cancer
; 18(4): e394-e401, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564556